about
Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesisIncreased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell LymphomaNeuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cellsIn-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures.Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells.Opposed expression of IKKα: loss in keratinizing carcinomas and gain in non-keratinizing carcinomas.Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises.Epigenetic Treatment of Persistent Viral Infections.The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses.Human oncogenic viruses: nature and discovery.Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.Genome-wide analysis of Epstein-Barr virus identifies variants and genes associated with gastric carcinoma and population structure.Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment.An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma.EBV based cancer prevention and therapy in nasopharyngeal carcinoma.Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
P2860
Q28077209-C59F6695-F718-4362-8705-7C2EDB4E1328Q30276132-8E2DA028-B38F-4408-A6EE-133C5F0D30F2Q35119824-C0900658-521D-4688-AC3B-D20D5E2AB4D0Q35823798-C8912E22-D74D-451F-B90E-D1A619CBFFB0Q36055637-CA6DFBD5-19AE-4EF3-8025-0CA44B46AB3DQ36413217-2FDDB5EB-23B7-4424-928E-3D79DB5CF9ECQ38568602-B06C4E6E-7865-450D-8F54-0B863561D6DEQ38692795-F063CB57-EEDB-4B31-8D0B-AD566536E497Q38985869-D68B7C6C-117E-4EC3-834E-3290E7A60CF7Q39545359-C94B04E7-72F0-4A41-A316-4536077D016CQ40046680-174A3A4E-3425-41F8-AE67-72D88C86998AQ40125313-DAD822D1-CDFB-4433-8B81-A629D8A23962Q45326308-285EE4B4-7403-4B5E-9C41-B755507A317FQ47239784-145EE856-DA9A-4A83-98E6-99FBD9343B37Q49787173-F348D404-EFFA-4853-BB05-7980C39FB9E2Q51629770-B4558F86-86C9-4633-A7EA-F514B9BBCA01Q55003883-BCDE2A8E-1A84-4894-B7A7-BF010B4527E8Q58803477-4350DF7A-6A8E-48B8-A637-38D980616715
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Virology. Epstein-Barr virus turns 50.
@ast
Virology. Epstein-Barr virus turns 50.
@en
type
label
Virology. Epstein-Barr virus turns 50.
@ast
Virology. Epstein-Barr virus turns 50.
@en
prefLabel
Virology. Epstein-Barr virus turns 50.
@ast
Virology. Epstein-Barr virus turns 50.
@en
P2860
P356
P1433
P1476
Virology. Epstein-Barr virus turns 50.
@en
P2093
Paul M Lieberman
P2860
P304
P356
10.1126/SCIENCE.1252786
P407
P577
2014-03-01T00:00:00Z